View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsHUTN 配当と自社株買い配当金 基準チェック /06HUTN配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Oct 06EF Hutton Announces Executive AppointmentsEF Hutton announced the hiring of James O’Neill and Jack Terranova as Co-heads of Healthcare. Mr. O’Neill will serve as Senior Managing Director and Head of Healthcare Equity Capital Markets and Mr. Terranova will serve as Managing Director and Head of Healthcare Investment Banking. The addition of Mr. O’Neill and Mr. Terranova comes after EF Hutton recently expanded its footprint in healthcare equity research with the hiring of Michael G. King, Jr. as Managing Director and Head of Healthcare Equity Research. James O’Neill brings over two decades of equity capital markets experience, most recently serving as the Head of Healthcare ECM at Oppenheimer & Co. Inc. Mr. O’Neill has also served in senior ECM roles at Roth Capital Markets, Rodman & Renshaw, and Cantor Fitzgerald. Jack Terranova has spent over 15 years focused on covering middle market and emerging growth healthcare companies, most recently serving as Managing Director, Healthcare Investment Banking at Oppenheimer & Co. Inc. Mr. O’Neill and Mr. Terranova have collectively completed over 500 financings and strategic advisory transactions and raised over $20 billion over their careers.お知らせ • Apr 06EF HUTTON AMERICA INC Appoints Duncan Swanston as Managing Director, Head of Structured ProductsEF HUTTON AMERICA INC Appoints Duncan Swanston, Managing Director, Head of Structured - Products. EF Hutton announced Duncan Swanston has joined the firm as Managing Director, Head of Structured Products. Duncan will oversee the Structured Products team and will be responsible for growing the business and his team, with several Wall Street veterans already committed to joining EF Hutton. Duncan has over 15 years of experience helping public and private corporations and borrowers reach their long- and short-term objectives by securing long-term flexible capital. He has closed over one hundred transactions for more than $15 billion in structured financing alone by tailoring transactions to meet the specific needs of each of his clients allowing for the lowest effective cost while maintaining the highest degree of flexibility. His investment banking experience spans across several sectors including investment grade and sub investment grade fixed income, debt and equity private placements, both rated and non-rated securitizations, capital markets, and real estate equity to include office, retail, industrial, governmental, healthcare, manufacturing, multi-family, and special purpose properties.お知らせ • Feb 09EF Hutton Appoints Ariel Imas as Senior Managing Director, Capital MarketsEF Hutton announced Ariel Imas has been appointed Senior Managing Director, Capital Markets. Mr. Imas has over twenty years of corporate finance and investment banking experience focused on the lower-middle markets. Throughout his career, he has closed over 150 transactions providing full-service banking and has spearheaded capital raises exceeding $1 billion dollars from: institutional investors via PIPEs, secondaries, follow-ons, registered directs, CMPOs, IPOs and M&A. Mr. Imas has also provided strategic advisory services for dozens of partner companies. His strength lies in the relationships he forges with C-Level executives and institutional investors, enabling Mr. Imas to build shareholder value for every deal he has participated in. Additionally, he has also paved the way for several entrepreneurial ventures as a co-founder of healthcare, technology, and financial services companies.決済の安定と成長配当データの取得安定した配当: HUTNの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: HUTNの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場HUTN 配当利回り対市場HUTN 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (HUTN)n/a市場下位25% (US)1.4%市場トップ25% (US)4.3%業界平均 (Interactive Media and Services)0.3%アナリスト予想 (HUTN) (最長3年)n/a注目すべき配当: HUTNは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: HUTNは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: HUTNの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: HUTNが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2025/01/14 03:29終値2024/10/17 00:00収益2015/12/31年間収益2015/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋HUTN, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Oct 06EF Hutton Announces Executive AppointmentsEF Hutton announced the hiring of James O’Neill and Jack Terranova as Co-heads of Healthcare. Mr. O’Neill will serve as Senior Managing Director and Head of Healthcare Equity Capital Markets and Mr. Terranova will serve as Managing Director and Head of Healthcare Investment Banking. The addition of Mr. O’Neill and Mr. Terranova comes after EF Hutton recently expanded its footprint in healthcare equity research with the hiring of Michael G. King, Jr. as Managing Director and Head of Healthcare Equity Research. James O’Neill brings over two decades of equity capital markets experience, most recently serving as the Head of Healthcare ECM at Oppenheimer & Co. Inc. Mr. O’Neill has also served in senior ECM roles at Roth Capital Markets, Rodman & Renshaw, and Cantor Fitzgerald. Jack Terranova has spent over 15 years focused on covering middle market and emerging growth healthcare companies, most recently serving as Managing Director, Healthcare Investment Banking at Oppenheimer & Co. Inc. Mr. O’Neill and Mr. Terranova have collectively completed over 500 financings and strategic advisory transactions and raised over $20 billion over their careers.
お知らせ • Apr 06EF HUTTON AMERICA INC Appoints Duncan Swanston as Managing Director, Head of Structured ProductsEF HUTTON AMERICA INC Appoints Duncan Swanston, Managing Director, Head of Structured - Products. EF Hutton announced Duncan Swanston has joined the firm as Managing Director, Head of Structured Products. Duncan will oversee the Structured Products team and will be responsible for growing the business and his team, with several Wall Street veterans already committed to joining EF Hutton. Duncan has over 15 years of experience helping public and private corporations and borrowers reach their long- and short-term objectives by securing long-term flexible capital. He has closed over one hundred transactions for more than $15 billion in structured financing alone by tailoring transactions to meet the specific needs of each of his clients allowing for the lowest effective cost while maintaining the highest degree of flexibility. His investment banking experience spans across several sectors including investment grade and sub investment grade fixed income, debt and equity private placements, both rated and non-rated securitizations, capital markets, and real estate equity to include office, retail, industrial, governmental, healthcare, manufacturing, multi-family, and special purpose properties.
お知らせ • Feb 09EF Hutton Appoints Ariel Imas as Senior Managing Director, Capital MarketsEF Hutton announced Ariel Imas has been appointed Senior Managing Director, Capital Markets. Mr. Imas has over twenty years of corporate finance and investment banking experience focused on the lower-middle markets. Throughout his career, he has closed over 150 transactions providing full-service banking and has spearheaded capital raises exceeding $1 billion dollars from: institutional investors via PIPEs, secondaries, follow-ons, registered directs, CMPOs, IPOs and M&A. Mr. Imas has also provided strategic advisory services for dozens of partner companies. His strength lies in the relationships he forges with C-Level executives and institutional investors, enabling Mr. Imas to build shareholder value for every deal he has participated in. Additionally, he has also paved the way for several entrepreneurial ventures as a co-founder of healthcare, technology, and financial services companies.